![]() |
« July 2014 | Main | September 2014 »
![]() |
Posted by NELB Staff on 08/28/2014 at 08:30 PM | Permalink | Comments (0)
Recently published in Neuroethics:
"Will There Ever Be a Drug with No or Negligible Side Effects? Evidence from Neuroscience," by Sylvia Terbeck and Laurence Paul Chesterman
Arguments in the neuroenhancement debate are sometimes based upon idealistic scenarios involving the assumption of using a drug that has no or negligible side effects. At least it is often implicitly assumed – as technology and scientific knowledge advances - that there soon will be a drug with no or negligible side effects. We will review evidence from neuroscience, complex network research and evolution theory and demonstrate that - at least in terms of psychopharmacological intervention – on the basis of our understanding of brain function it seems inconceivable that there ever will be a drug that has the desired effect without undesirable side effects. We will illustrate this by reference to enhancing edge detection in V2 in monkeys and demonstrate that even for this localised single neuron coded function there would be numerous side effects. Taking the more realistic case of pharmacological enhancement that is inevitably associated with side effects will change consequentialist arguments for neuroenhancement and have implications for the conception of autonomy, specifically in the case of performance enhancement. We conclude that a neuroethics debate that aims to inform policy decisions should take these findings into account. We hope that our article will precipitate more interdisciplinary research in neuroscience and philosophy.
Posted by NELB Staffer #2 on 08/28/2014 at 06:37 AM | Permalink | Comments (0)
Recently published in Neuroethics:
"Public Attitudes Toward Cognitive Enhancement," by Nicholas S. F itz, Roland Nadler, Praveena Manogaran, Eugene W. J. Chong, and Peter B. Reiner.
Vigorous debate over the moral propriety of cognitive enhancement exists, but the views of the public have been largely absent from the discussion. To address this gap in our knowledge, four experiments were carried out with contrastive vignettes in order to obtain quantitative data on public attitudes towards cognitive enhancement. The data collected suggest that the public is sensitive to and capable of understanding the four cardinal concerns identified by neuroethicists, and tend to cautiously accept cognitive enhancement even as they recognize its potential perils. The public is biopolitically moderate, endorses both meritocratic principles and the intrinsic value of hard work, and appears to be sensitive to the salient moral issues raised in the debate. Taken together, these data suggest that public attitudes toward enhancement are sufficiently sophisticated to merit inclusion in policy deliberations, especially if we seek to align public sentiment and policy.
Posted by NELB Staffer #2 on 08/27/2014 at 12:37 PM | Permalink | Comments (0)
This recently published in Neuroethics:
"The Science of Morality and its Normative Implications" by Tommaso Bruni, Matteo Mameli, and Regina A. Rini.
Abstract:
Neuromoral theorists are those who claim that a scientific understanding of moral judgment through the methods of psychology, neuroscience and related disciplines can have normative implications and can be used to improve the human ability to make moral judgments. We consider three neuromoral theories: one suggested by Gazzaniga, one put forward by Gigerenzer, and one developed by Greene. By contrasting these theories we reveal some of the fundamental issues that neuromoral theories in general have to address. One important issue concerns whether the normative claims that neuromoral theorists would like to make are to be understood in moral terms or in non-moral terms. We argue that, on either a moral or a non-moral interpretation of these claims, neuromoral theories face serious problems. Therefore, neither the moral nor the non-moral reading of the normative claims makes them philosophically viable.
Posted by NELB Staffer #2 on 08/27/2014 at 12:22 PM | Permalink | Comments (0)
Recently published in Neuroethics:
"Exploring Some Challenges of the Pharmaceutical Cognitive Enhancement Discourse: Users and Policy Recommendations" by Toni Pustovrh and Franc Mali
The article explores some of the issues that have arisen in the discourse on pharmaceutical cognitive enhancement (PCE), that is, the use of stimulant drugs such as methylphenidate, amphetamine and modafinil by healthy individuals of various populations with the aim of improving cognitive performance. Specifically, we explore the presumed sizes of existing PCE user populations and the policy actions that have been proposed regarding the trend of PCE. We begin with an introductory examination of the academic stances and philosophical issues involved in defining PCE. We then focus on an examination of the population sizes of presumed current PCE users that have been listed in the academic literature on PCE, on presuppositions, which have been problematized by some authors as based on anecdotal or misinterpreted survey data. We follow this with an empirical examination of a potential PCE user population in a national context (students at the University of Ljubljana in Slovenia). We then proceed to examine the regulatory options proposed in the academic literature to address PCE, finally comparing them with an empirical overview of the policy recommendations on PCE produced in the multinational context of several national ethics advisory bodies (EABs) in Europe. Our main conclusion is that there is still little debate among the national EABs on what type of public policy responses, if any, are needed to address PCE in European countries, and that the issues they do address are similar to those discussed and proposed in the academic articles on PCE.
Posted by NELB Staffer #2 on 08/22/2014 at 11:00 AM | Permalink | Comments (0)
![]() |
Last Edition's Most Popular Article(s):
In The Popular Press:
|
||
|
Posted by NELB Staff on 08/21/2014 at 09:41 PM | Permalink | Comments (0)
Recently published in Neuroethics:
"Autonomy and Enhancement", by G. Owen Schaefer, Guy Kahane, and Julian Savulescu
Some have objected to human enhancement on the grounds that it violates the autonomy of the enhanced. These objections, however, overlook the interesting possibility that autonomy itself could be enhanced. How, exactly, to enhance autonomy is a difficult problem due to the numerous and diverse accounts of autonomy in the literature. Existing accounts of autonomy enhancement rely on narrow and controversial conceptions of autonomy. However, we identify one feature of autonomy common to many mainstream accounts: reasoning ability. Autonomy can then be enhanced by improving people’s reasoning ability, in particular through cognitive enhancement; given how valuable autonomy is usually taken to be, this gives us extra reason to pursue such cognitive enhancements. Moreover, autonomy-based objections will be especially weak against such enhancements. As we will argue, those who are worried that enhancements will inhibit people’s autonomy should actually embrace those enhancements that will improve autonomy.
Posted by NELB Staffer #2 on 08/15/2014 at 05:30 AM | Permalink | Comments (0)
Posted by NELB Staff on 08/14/2014 at 05:00 PM | Permalink | Comments (0)
Posted by NELB Staff on 08/14/2014 at 04:30 PM | Permalink | Comments (0)
![]() |
Last Edition's Most Popular Article(s):
In The Popular Press:
From the Academic Literature:
|
||
|
Posted by NELB Staff on 08/14/2014 at 03:35 PM | Permalink | Comments (0)
Recently published in Neuroethics:
"Ethical Challenges Associated with the Development and Deployment of Brain Computer Interface Technology" by Paul McCullagh, Gaye Lightbody, Jaroslaw Zygierewicz, and W. George Kernohan.
Abstract
Brain Computer Interface (BCI) technology offers potential for human augmentation in areas ranging from communication to home automation, leisure and gaming. This paper addresses ethical challenges associated with the wider scale deployment of BCI as an assistive technology by documenting issues associated with the development of non-invasive BCI technology. Laboratory testing is normally carried out with volunteers but further testing with subjects, who may be in vulnerable groups is often needed to improve system operation. BCI development is technically complex, sometimes requiring lengthy recording sessions to achieve the necessary personalisation of the paradigms, and this can present ethical challenges that vary depending on the subject group. The paper contributes to the on-going ethical discussion surrounding the deployment BCI outside the specialist laboratory and suggests some tentative guidelines for BCI research teams, appropriate to those deploying the technology, derived from experience on a multisite project. Any tension between deployment and technical progress must be managed by a formal process within a multidisciplinary consortium.
Posted by NELB Staffer #2 on 08/14/2014 at 11:23 AM | Permalink | Comments (0)
![]() |
Last Edition's Most Popular Article(s):
In The Popular Press:
From the Academic Literature:
|
||
|
Posted by NELB Staff on 08/07/2014 at 09:40 PM | Permalink | Comments (0)
Short but sweet commentary on neurohype in the form of a cartoon.
Posted by Adam Kolber on 08/07/2014 at 05:05 AM | Permalink | Comments (0)
I'm pleased to be a member of the editorial board of this new journal. Here is an introductory message from the editor-in-chief:
Many of today’s policy questions require an interdisciplinary approach, drawing from fields such as neuroscience, biology, and statistics. Researchers today are presented with new technologies to gather data and novel techniques for data mining. However, innovative scholarship often fails to leave its subspecialty and reach an interdisciplinary audience, dulling its impact and preventing other disciplines from capitalizing on new findings.
The Journal of Science and Law (JSciLaw) seeks to address this problem as an interdisciplinary publication that provides a forum for scholarship at the intersection of scientific research and legal policy. JSciLaw aims to unite disciplines and to encourage collaboration between scientific researchers, legal scholars, and policy makers. Reflecting its interdisciplinary nature, the JSciLaw editorial board includes scholars from the fields of neuroscience, law, criminology, statistics, and policy.
JSciLaw promotes top-tier, peer-reviewed scientific research that matters for policy decisions. Reflecting that mission, we are pioneering in-house journal software that allows JSciLaw to incorporate large-scale data directly into its manuscripts, such that reported results are replicable and extensible (See here for an example). In this way, readers are not forced to simply believe the claims of research papers published in JSciLaw, but can analyze the data themselves.
The journal is open-access, with all articles available for free at JSciLaw.org. Because we are an online journal, we are de-emphasizing word limits in deference to quality: articles should be as long as they need to be (but no longer). We publish Original Research Articles, Reviews, Opinions, and occasionally, Book Reviews. Papers are published on a rolling basis as soon as they are accepted.
JSciLaw encourages you to submit your innovative research and to explore our research articles in the future.
David M. Eagleman, PhD
Editor-in-Chief
Director, Initiative on Neuroscience and Law
Department of Neuroscience, Baylor College of Medicine
Posted by Adam Kolber on 08/02/2014 at 09:28 AM | Permalink | Comments (0)